A phase II and co-clinical study of an AKT inhibitor in patients (pts) with biomarker-enriched, previously treated metastatic colorectal cancer (mCRC)
Amer Academy Dermat Meeting Abstracts
doi: 10.1038/nature05859 108 HuoGLinYLiuLHeYQuYLiuYet al
To optimize SeNPs concentration for subsequent semen cryopreservation, three semen samples were individually split into four equals and diluted to a final concentration of 6.0 10 7 spermatozoa/ml with the basic extender supplemented with 0 g/ml SeNPs, 1 g/ml SeNPs, 2 g/ml SeNPs, and 4 g/ml SeNPs
74.3%), and/or pruritus (n = 64
These data indicate that GLP-1RA/tesaglitazar possesses, particularly at low concentrations, a substantially enhanced potency to acutely improve glucose tolerance relative to the GLP-1RA monotherapy